Form 4: DarioHealth Corp. CFO Acquires 500,000 Shares of Common Stock

Chen Franco-Yehuda, CFO of DarioHealth Corp., acquired 500,000 shares of common stock on May 15, 2025, as reported in a Form 4 filing with the SEC.

Summary

• On May 15, 2025, Chen Franco-Yehuda, the Chief Financial Officer of DarioHealth Corp., acquired 500,000 shares of common stock.
• The acquisition was a direct transaction.
• The price per share was $0.
• The shares are restricted and vest over three years, with one-third vesting on April 27, 2026, and the remainder vesting quarterly, contingent on continued service.
• Vesting will accelerate upon a change in control of DarioHealth Corp.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The CFO acquiring shares suggests confidence, but it's a standard transaction.

Positives

• The CFO's acquisition of a significant number of shares could be interpreted as a sign of confidence in the company's future prospects.

Risks

• The vesting of the shares is contingent on continued service, so the CFO leaving the company could impact the share structure.
• The accelerated vesting upon a change in control could create additional costs or dilution in the event of an acquisition.

Future Outlook

The document does not contain explicit forward-looking statements, but the vesting schedule implies a multi-year commitment from the CFO.

Industry Context

Form 4 filings are standard disclosures for corporate insiders and provide transparency into their transactions in company stock.

Stakeholder Impact

• The acquisition could have a slightly positive impact on shareholder sentiment, as it signals confidence from a key executive.

Key Dates

Keywords

DarioHealth Corp, Chen Franco-Yehuda, CFO, Form 4, SEC, stock acquisition, share vesting, equity